Finance

Lists
Why is 300039 down 2,45%?
Dive Deeper
300039:SHE
Shanghai Kaibao Pharmaceutical Co Ltd
CN¥5,17
-2,45%
(-0,13) 1D
8 Okt., 15:04:07 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300039...
Open
CN¥5,34
High
CN¥5,38
Low
CN¥5,15
Mkt. cap
5,54 mjd
Avg. vol.
30,13 m
Volume
19,38 m
Dividend
2,51%
Quarterly dividend
CN¥0,03
Ex-dividend date
29 Mei 2026
P/E ratio
20,91
52-wk high
CN¥6,77
52-wk low
CN¥4,02
EPS
CN¥0,25
Shares outstanding
1,05 mjd
No. of employees
1 k
Open
CN¥5,34
High
CN¥5,38
Low
CN¥5,15
Mkt. cap
5,54 mjd
Avg. vol.
30,13 m
Volume
19,38 m
Dividend
2,51%
Quarterly dividend
CN¥0,03
Ex-dividend date
29 Mei 2026
P/E ratio
20,91
52-wk high
CN¥6,77
52-wk low
CN¥4,02
EPS
CN¥0,25
Shares outstanding
1,05 mjd
No. of employees
1 k
News stories
From web sources and news partners
About Shanghai Kaibao Pharmaceutical Co Ltd
CEO-
Employees1,2 k
Founded12 Apr. 2000
Headquarters-
SectorPharmaceutical industry
Websitexykb.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
214,37 m
333,63 m
283,25 m
179,67 m
Cost of goods sold
43,67 m
64,49 m
54,33 m
37,80 m
Cost of revenue
43,67 m
64,49 m
54,33 m
37,80 m
Research and development expenses
8,86 m
25,01 m
19,42 m
20,50 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
106,04 m
148,00 m
137,79 m
88,60 m
Operating expense
114,94 m
185,39 m
159,80 m
106,63 m
Total operating expenses
158,60 m
249,87 m
214,13 m
144,42 m
Operating income
55,77 m
83,76 m
69,12 m
35,25 m
Other non operating income
-23,48 k
-14,50 k
-15,08 k
-284,72 k
EBT including unusual items
75,82 m
101,69 m
77,06 m
44,44 m
EBT excluding unusual items
74,92 m
104,13 m
77,58 m
44,02 m
Income tax expense
10,85 m
10,35 m
12,31 m
7,46 m
Effective tax rate
14,31%
10,18%
15,97%
16,79%
Other operating expenses
202,62 k
8,82 m
4,21 m
3,04 m
Net income
65,09 m
91,54 m
64,87 m
37,07 m
Net profit margin
30,36%
27,44%
22,90%
20,63%
Earnings per share
-
-
-
-
Interest and investment income
19,21 m
20,41 m
8,51 m
9,09 m
Interest expense
-32,96 k
-21,18 k
-39,73 k
-40,17 k
Net interest expenses
19,17 m
20,39 m
8,47 m
9,05 m
Depreciation and amortization charges
-
-
-
-
EBITDA
64,62 m
92,13 m
77,49 m
43,92 m
Gain or loss from assets sale
187,25 k
-39,32 k
-
57,03 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme